secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avantor, Inc. (AVTR)
CIK:        0001722482
Form:       8-K
Filed at:   2025-02-07T23:59:59+00:00
Accession:  0001722482-25-000013
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avantor Q4 organic growth 1%, adjusted EPS $0.27; full-year adjusted EPS $0.99
------------------------------------------------------------------------------

- Q4 net sales $1.69B, down 2% reported; organic growth 1% with bioprocessing up high-single digits.
- Q4 GAAP EPS $0.73 (net income $500.4M); adjusted EPS $0.27; adjusted EBITDA margin 18.2%.
- Full-year net sales $6.78B, down 3% reported; organic decline 2%; adjusted EBITDA $1.20B margin 17.7%.
- Free cash flow Q4 $222.1M; full-year $768.3M; adjusted net leverage 3.2x as of Dec 31, 2024.
- Bioscience Production segment Q4 net sales up 4% organic; Laboratory Solutions down 1% organic.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722482/000172248225000013/0001722482-25-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722482/000172248225000013/avtr-20250207.htm
  HTML page:      https://secwatch.observer/filing/0001722482-25-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer